NCT05260307 Improving Spatial Perception and Speech Understanding in Multitalker Mixtures
| NCT ID | NCT05260307 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston University Charles River Campus |
| Condition | Hearing Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 220 participants |
| Start Date | 2022-03-09 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 220 participants in total. It began in 2022-03-09 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate several approaches for improving spatial perception and speech intelligibility in multitalker listening situations for hearing-aid users. The hypotheses are that spatial perception and speech intelligibility will be improved by (1) increased high-frequency audibility, (2) speech envelope enhancement, and/or (3) appropriate sound image externalization.
Eligibility Criteria
Inclusion Criteria: Normal-Hearing Subjects * 18 to 35 years of age * Audiometric thresholds that do not exceed 20 dB HL at any frequency from 250 to 8000 Hz * Able to provide informed consent and understand experimental instructions * Normal or corrected-to-normal vision Inclusion Criteria: Hearing-Impaired Subjects * 18 to 80 years of age * Documented sensorineural hearing loss * Able to provide informed consent and understand experimental instructions * Normal or corrected-to-normal vision Exclusion Criteria (some experiments) * Non-native speakers of English
Contact & Investigator
Virginia A Best, PhD
PRINCIPAL INVESTIGATOR
Boston University
Frequently Asked Questions
Who can join the NCT05260307 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Hearing Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05260307 currently recruiting?
Yes, NCT05260307 is actively recruiting participants. Contact the research team at ginbest@bu.edu for enrollment information.
Where is the NCT05260307 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT05260307 clinical trial?
NCT05260307 is sponsored by Boston University Charles River Campus. The principal investigator is Virginia A Best, PhD at Boston University. The trial plans to enroll 220 participants.